REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Novoderma Pharma S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers | Retail Trade
Full name: Novoderma Pharma S.A. Profile Updated: April 10, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Novoderma Pharma S.A. is based in Ecuador, with the head office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on April 24, 2019. From the latest financial highlights, Novoderma Pharma S.A. reported a net sales revenue drop of 91.31% in 2022. Its’ total assets recorded a growth of 2.66%. The enterprise’s net profit margin decreased by 48.19% in 2022.

Headquarters
Av. el Inca E4-264
Quito; Pichincha;

Contact Details: Purchase the Novoderma Pharma S.A. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Novoderma Pharma S.A. report to view the information.
Registered Capital:
Purchase the Novoderma Pharma S.A. report to view the information.
Incorporation Date:
April 24, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Novoderma Pharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-91.31%▼
Total operating revenue
-91.31%▼
Operating profit (EBIT)
-95.55%▼
Net Profit (Loss) for the Period
-97.1%▼
Total assets
2.66%▲
Total equity
1.97%▲
Operating Profit Margin (ROS)
-37.33%▼
Net Profit Margin
-48.19%▼
Return on Equity (ROE)
-66.07%▼
Quick Ratio
-3.89%▼
Cash Ratio
-3.24%▼

Similar companies

Laboratorios Siegfried S.A.
 
Roche Ecuador S.A.
Bayer S.A.
 
Novartis Ecuador S.A.
Laboratorios Industriales Farmaceuticos Ecuatorianos Life
 
Farmayala Pharmaceutical Company S.A.
Green - Natura Labs Cia.Ltda
 
Deeam Pharmaceutical S.A.
Promunec S.A.S.
 
Trujitrade S.A.
Wonderlife Cia.Ltda
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo